查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631223

化妆品用胜肽製造的全球市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2032年)

Cosmetic Peptide Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 224 Pages | 商品交期: 2-5个工作天内

价格
简介目录

受技术进步、消费者对抗老化解决方案的需求不断增长以及对永续美容产品的日益关注的推动，化妆品胜肽製造市场正在经历前所未有的增长。胜肽因其能够针对衰老、色素沉着和保湿等特定皮肤问题而闻名，已成为现代护肤配方中必不可少的成分。全球化妆品胜肽製造市场规模预计将以 5.6% 的复合年增长率成长，到 2025 年达到 2.47 亿美元，到 2032 年达到 3.6177 亿美元。推动这一成长的是生物技术的突破，它彻底改变了胜肽的合成，使其能够精确配製以满足消费者的需求。

胜肽能够解决多种皮肤问题，其多功能性使其成为化妆品配方的重要组成部分。随着消费者偏好的不断变化和技术进步，化妆品胜肽製造市场将大幅成长。胜肽合成的技术创新，加上个人化和永续皮肤护理的兴起，使这个市场成为美容和个人护理行业的变革力量。随着主要参与者推动技术创新和区域市场提供多样化机会，该行业有望重新定义现代护肤解决方案。

透过开发源自可再生资源或由可生物降解材料製成的胜肽，製造商可以满足有环保意识的消费者的需求并利用清洁美容趋势。南亚和太平洋等地区的快速城市化和可支配收入的增加为市场扩张提供了机会。利用人工智慧护肤分析和数位平台进行产品客製化可以提高消费者的参与度和忠诚度。

本报告提供全球化妆品用胜肽製造市场相关调查，提供市场概要，以及各产品，各用途，最终产品，各终端用户，及各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
  • 波特的五力分析
  • COVID-19影响分析
  • 乌克兰·俄罗斯纠纷的影响
  • 经济概要
  • 大环境分析

第3章 全球化妆品用胜肽製造市场预测，2019年～2032年

  • 全球化妆品用胜肽製造市场预测，各产品，金额(100万美元)，2019年～2032年
  • 全球化妆品用胜肽製造市场预测，各用途，金额(100万美元)，2019年～2032年
  • 全球化妆品用胜肽製造市场预测，最终产品，金额(100万美元)，2019年～2032年
  • 全球化妆品用胜肽製造市场预测，各终端用户，金额(100万美元)，2019年～2032年
  • 全球化妆品用胜肽製造市场预测，各地区，金额(100万美元)，2019年～2032年

第4章 北美的化妆品用胜肽製造市场预测，2019年～2032年

第5章 欧洲的化妆品用胜肽製造市场预测，2019年～2032年

第6章 亚太地区的化妆品用胜肽製造市场预测，2019年～2032年

第7章 南美的化妆品用胜肽製造市场预测，2019年～2032年

第8章 中东·非洲的化妆品用胜肽製造市场预测，2019年～2032年

第9章 竞争情形

  • 企业市场占有率分析，2024年
  • 竞争仪表板
  • 企业简介
    • Croda International plc
    • Merck KGaA
    • USV Private Limited
    • BASF SE
    • CEM Corporation
    • Bachem Holding AG
    • CPC Scientific Inc.
    • Creative Peptides
    • Bio-Synthesis Inc.
    • CSBio China

第10章 附录

简介目录

The cosmetic peptide manufacturing market is experiencing unprecedented growth, fueled by technological advancements, increasing consumer demand for anti-aging solutions, and a rising focus on sustainable beauty products. Peptides, known for their ability to target specific skin concerns such as aging, pigmentation, and hydration, have become essential components in modern skincare formulations. The global cosmetic peptide manufacturing market is projected to grow at a CAGR of 5.6%, reaching a value of USD 247 million by 2025 and USD 361.77 million by 2032. This growth is driven by breakthroughs in biotechnology that have revolutionized the synthesis of peptides, enabling precise formulations tailored to consumer needs

Market Insights

The global cosmetic peptide manufacturing market is projected to grow at a CAGR of 5.6%, reaching a value of USD 247 million by 2025 and USD 361.77 million by 2032. This growth is driven by breakthroughs in biotechnology that have revolutionized the synthesis of peptides, enabling precise formulations tailored to consumer needs. Peptides' versatility in addressing multiple skin concerns has positioned them as indispensable in cosmetic formulations. The cosmetic peptide manufacturing market is poised for substantial growth as it aligns with evolving consumer preferences and technological advancements. Innovations in peptide synthesis, coupled with the rise of personalized and sustainable skincare, position this market as a transformative force in the beauty and personal care industry. With key players driving innovation and regional markets presenting diverse opportunities, the industry is set to redefine modern skincare solutions.

Drivers of Growth

  • 1. Advances in Biotechnology: Innovative techniques such as solid-phase peptide synthesis and recombinant DNA technology have enhanced the efficiency and specificity of peptide production, enabling the development of cutting-edge skincare solutions.
  • 2. Rising Demand for Anti-Aging Products: Consumers increasingly seek products that address visible signs of aging, such as wrinkles and fine lines. Peptides, known for stimulating collagen production and promoting skin elasticity, are at the forefront of this trend.
  • 3. Sustainability and Clean Beauty Movement: The growing emphasis on sustainable and eco-friendly beauty solutions has prompted manufacturers to develop green peptide formulations, aligning with consumer preferences for environmentally conscious products.
  • 4. Personalized Skincare: Advances in technology have enabled personalized skincare solutions, allowing manufacturers to create bespoke peptide formulations tailored to individual needs, further driving market growth.

Business Opportunities

  • 1. Sustainable Peptide Formulations: Manufacturers can capitalize on the clean beauty trend by developing peptides derived from renewable resources or utilizing biodegradable materials, catering to environmentally conscious consumers.
  • 2. Expansion into Emerging Markets: Rapid urbanization and increasing disposable income in regions such as South Asia and the Pacific present lucrative opportunities for market expansion.
  • 3. Integration of AI and Digital Technologies: Leveraging AI-driven skincare analysis and digital platforms for product customization can enhance consumer engagement and loyalty.

Regional Analysis

  • 1. Europe: The Market Leader Europe dominates the cosmetic peptide manufacturing market due to its advanced industry infrastructure, stringent regulatory standards, and strong R&D capabilities. The region's focus on premium beauty products further bolsters its leadership position.
  • 2. South Asia & Pacific: A Rapidly Growing Market With a thriving beauty and personal care industry, the South Asia & Pacific region is witnessing accelerated growth. Factors such as an aging population, rising skincare awareness, and advancements in healthcare infrastructure contribute to this region's market expansion.

Key Players Prominent companies driving innovation and market growth include:

  • Croda International Plc
  • Ashland
  • DSM (Koninklijke DSM NV)
  • Bachem
  • Genscript Biotech Corp
  • BASF SE
  • Geltor
  • The Lubrizol Corporation
  • Symrise
  • Bio Basic Inc.
  • Regeron Inc.

Market Segmentation The cosmetic peptide manufacturing market is segmented based on product type, application, end-user, and region.

1. By Product Type:

    Signal Peptides Neurotransmitter Inhibitors Carrier Peptides Enzyme Inhibitor Peptides Structural Peptides Synthetic Antimicrobial Peptides (AMPs) Others

2. By Application:

    Anti-Aging Eye Care Anti-Pigmentation Hair Growth

3. By End User:

    Cosmetic Manufacturers Cosmetic Contract Manufacturers Biopharmaceutical Industries (Personal Care)

4. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cosmetic Peptide Manufacturing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Porter's Five Forces Analysis
  • 2.4. COVID-19 Impact Analysis
    • 2.4.1. Supply
    • 2.4.2. Demand
  • 2.5. Impact of Ukraine-Russia Conflict
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Global Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 3.1. Global Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Neurotransmitter Inhibitors
      • 3.1.1.2. Enzyme Inhibitor Peptides
      • 3.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 3.1.1.4. Signal Peptides
      • 3.1.1.5. Carrier Peptides
      • 3.1.1.6. Others
  • 3.2. Global Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Whitening
      • 3.2.1.2. Anti-Aging
      • 3.2.1.3. Hair/Eyecare/Eyelash Care
      • 3.2.1.4. Slimming & Breast Enhancement
      • 3.2.1.5. Others
  • 3.3. Global Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Skin Care
        • 3.3.1.1.1. Sunscreen Lotion
        • 3.3.1.1.2. Serum
        • 3.3.1.1.3. Creams and Moisturizers
      • 3.3.1.2. Eye Care
        • 3.3.1.2.1. Serum
        • 3.3.1.2.2. Cream
      • 3.3.1.3. Hair Care
        • 3.3.1.3.1. Serum
        • 3.3.1.3.2. Cream
      • 3.3.1.4. Others
  • 3.4. Global Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. Cosmetic Manufacturers
      • 3.4.1.2. Cosmetic Contract Manufacturers
      • 3.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 3.5. Global Cosmetic Peptide Manufacturing Market Outlook, by Region, Value (US$ Mn), 2019 - 2032
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 4.1. North America Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Neurotransmitter Inhibitors
      • 4.1.1.2. Enzyme Inhibitor Peptides
      • 4.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 4.1.1.4. Signal Peptides
      • 4.1.1.5. Carrier Peptides
      • 4.1.1.6. Others
  • 4.2. North America Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Whitening
      • 4.2.1.2. Anti-Aging
      • 4.2.1.3. Hair/Eyecare/Eyelash Care
      • 4.2.1.4. Slimming & Breast Enhancement
      • 4.2.1.5. Others
  • 4.3. North America Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Skin Care
        • 4.3.1.1.1. Sunscreen Lotion
        • 4.3.1.1.2. Serum
        • 4.3.1.1.3. Creams and Moisturizers
      • 4.3.1.2. Eye Care
        • 4.3.1.2.1. Serum
        • 4.3.1.2.2. Cream
      • 4.3.1.3. Hair Care
        • 4.3.1.3.1. Serum
        • 4.3.1.3.2. Cream
      • 4.3.1.4. Others
  • 4.4. North America Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Cosmetic Manufacturers
      • 4.4.1.2. Cosmetic Contract Manufacturers
      • 4.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 4.5. North America Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.2. U.S. Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 4.5.1.3. U.S. Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.4. U.S. Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 4.5.1.5. Canada Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.6. Canada Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 4.5.1.7. Canada Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.8. Canada Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 5.1. Europe Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Neurotransmitter Inhibitors
      • 5.1.1.2. Enzyme Inhibitor Peptides
      • 5.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 5.1.1.4. Signal Peptides
      • 5.1.1.5. Carrier Peptides
      • 5.1.1.6. Others
  • 5.2. Europe Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Whitening
      • 5.2.1.2. Anti-Aging
      • 5.2.1.3. Hair/Eyecare/Eyelash Care
      • 5.2.1.4. Slimming & Breast Enhancement
      • 5.2.1.5. Others
  • 5.3. Europe Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Skin Care
        • 5.3.1.1.1. Sunscreen Lotion
        • 5.3.1.1.2. Serum
        • 5.3.1.1.3. Creams and Moisturizers
      • 5.3.1.2. Eye Care
        • 5.3.1.2.1. Serum
        • 5.3.1.2.2. Cream
      • 5.3.1.3. Hair Care
        • 5.3.1.3.1. Serum
        • 5.3.1.3.2. Cream
      • 5.3.1.4. Others
  • 5.4. Europe Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Cosmetic Manufacturers
      • 5.4.1.2. Cosmetic Contract Manufacturers
      • 5.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 5.5. Europe Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.2. Germany Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.3. Germany Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.4. Germany Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.5. U.K. Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.6. U.K. Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.7. U.K. Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.8. U.K. Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.9. France Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.10. France Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.11. France Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.12. France Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.13. Italy Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.14. Italy Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.15. Italy Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.16. Italy Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.17. Turkey Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.18. Turkey Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.19. Turkey Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.20. Turkey Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.21. Russia Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.22. Russia Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.23. Russia Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.24. Russia Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.25. Rest of Europe Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.26. Rest of Europe Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.27. Rest of Europe Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.28. Rest of Europe Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Neurotransmitter Inhibitors
      • 6.1.1.2. Enzyme Inhibitor Peptides
      • 6.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 6.1.1.4. Signal Peptides
      • 6.1.1.5. Carrier Peptides
      • 6.1.1.6. Others
  • 6.2. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Whitening
      • 6.2.1.2. Anti-Aging
      • 6.2.1.3. Hair/Eyecare/Eyelash Care
      • 6.2.1.4. Slimming & Breast Enhancement
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Skin Care
        • 6.3.1.1.1. Sunscreen Lotion
        • 6.3.1.1.2. Serum
        • 6.3.1.1.3. Creams and Moisturizers
      • 6.3.1.2. Eye Care
        • 6.3.1.2.1. Serum
        • 6.3.1.2.2. Cream
      • 6.3.1.3. Hair Care
        • 6.3.1.3.1. Serum
        • 6.3.1.3.2. Cream
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Cosmetic Manufacturers
      • 6.4.1.2. Cosmetic Contract Manufacturers
      • 6.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 6.5. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.2. China Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.3. China Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.4. China Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.5. Japan Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.6. Japan Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.7. Japan Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.8. Japan Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.9. South Korea Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.10. South Korea Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.11. South Korea Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.12. South Korea Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.13. India Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.14. India Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.15. India Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.16. India Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.17. Southeast Asia Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.18. Southeast Asia Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.19. Southeast Asia Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.20. Southeast Asia Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.21. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.22. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.23. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.24. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 7.1. Latin America Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Neurotransmitter Inhibitors
      • 7.1.1.2. Enzyme Inhibitor Peptides
      • 7.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 7.1.1.4. Signal Peptides
      • 7.1.1.5. Carrier Peptides
      • 7.1.1.6. Others
  • 7.2. Latin America Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Whitening
      • 7.2.1.2. Anti-Aging
      • 7.2.1.3. Hair/Eyecare/Eyelash Care
      • 7.2.1.4. Slimming & Breast Enhancement
      • 7.2.1.5. Others
  • 7.3. Latin America Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Skin Care
        • 7.3.1.1.1. Sunscreen Lotion
        • 7.3.1.1.2. Serum
        • 7.3.1.1.3. Creams and Moisturizers
      • 7.3.1.2. Eye Care
        • 7.3.1.2.1. Serum
        • 7.3.1.2.2. Cream
      • 7.3.1.3. Hair Care
        • 7.3.1.3.1. Serum
        • 7.3.1.3.2. Cream
      • 7.3.1.4. Others
  • 7.4. Latin America Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Cosmetic Manufacturers
      • 7.4.1.2. Cosmetic Contract Manufacturers
      • 7.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 7.5. Latin America Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.2. Brazil Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.3. Brazil Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.4. Brazil Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.5. Mexico Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.6. Mexico Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.7. Mexico Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.8. Mexico Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.9. Argentina Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.10. Argentina Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.11. Argentina Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.12. Argentina Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.13. Rest of Latin America Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.14. Rest of Latin America Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.15. Rest of Latin America Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.16. Rest of Latin America Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Neurotransmitter Inhibitors
      • 8.1.1.2. Enzyme Inhibitor Peptides
      • 8.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 8.1.1.4. Signal Peptides
      • 8.1.1.5. Carrier Peptides
      • 8.1.1.6. Others
  • 8.2. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Whitening
      • 8.2.1.2. Anti-Aging
      • 8.2.1.3. Hair/Eyecare/Eyelash Care
      • 8.2.1.4. Slimming & Breast Enhancement
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Skin Care
        • 8.3.1.1.1. Sunscreen Lotion
        • 8.3.1.1.2. Serum
        • 8.3.1.1.3. Creams and Moisturizers
      • 8.3.1.2. Eye Care
        • 8.3.1.2.1. Serum
        • 8.3.1.2.2. Cream
      • 8.3.1.3. Hair Care
        • 8.3.1.3.1. Serum
        • 8.3.1.3.2. Cream
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Cosmetic Manufacturers
      • 8.4.1.2. Cosmetic Contract Manufacturers
      • 8.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 8.5. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.2. GCC Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.3. GCC Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.4. GCC Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.5. South Africa Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.6. South Africa Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.7. South Africa Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.8. South Africa Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.9. Egypt Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.10. Egypt Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.11. Egypt Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.12. Egypt Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.13. Nigeria Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.14. Nigeria Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.15. Nigeria Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.16. Nigeria Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.17. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.18. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.19. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.20. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2024
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Croda International plc
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Merck KGaA
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. USV Private Limited
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. BASF SE
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. CEM Corporation
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Bachem Holding AG
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. CPC Scientific Inc.
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Creative Peptides
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Bio-Synthesis Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. CSBio China
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Product Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations